The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27774126 |
95 |
Exploring![EBI](/images/logo_chembl.png) |
University of California San Francisco |
32094009 |
36 |
Novel cilengitide-based cyclic RGD peptides as ?v?![EBI](/images/logo_chembl.png) |
Division of Organic Chemistry Csir-National Chemical Laboratory (Ncl) |
30657681 |
262 |
Selective Targeting of Integrin ?v?8 by a Highly Active Cyclic Peptide.![EBI](/images/logo_chembl.png) |
Technische Universit£T M£Nchen |
31381331 |
70 |
Profile of a Highly Selective Quaternized Pyrrolidine Betaine ?![EBI](/images/logo_chembl.png) |
Glaxosmithkline Medicines Research Centre |
24568695 |
76 |
Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists.![EBI](/images/logo_chembl.png) |
University of Bradford |
25408832 |
152 |
Structure Activity Relationships of ?v Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents.![EBI](/images/logo_chembl.png) |
University of Nottingham |
30215258 |
228 |
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic ?![EBI](/images/logo_chembl.png) |
University of Strathclyde |